Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
4
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
nonalcoholic steatohepatitis
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
cancer
eli lilly
fda
startups
alzheimer's disease
astrazeneca
biogen
car-t immunotherapy
What
bio
roundup
drug
companies
nash
news
abbvie’s
ahead
alzheimer’s
annual
approval
approved
assessed
attention
biofourmis
biogen’s
biopharmaceutical
biotech
bucks
cancer
celebrate
chance
communities
conference
convo
corner
day
days
digital
disease
earlier
epidemic
esmo
europe
failures
fatty
fda
forward
frenzied
germany
Language
unset
Current search:
abbvie
×
" nonalcoholic steatohepatitis "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
